Home › Agent Hub › Agent Tools › Part D coverage by drug › Meclizine
Agent Tools
Meclizine is a generic drug. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 4,730 of 5,492 Medicare Part D and Medicare Advantage drug plans (86.1%) list Meclizine on their formulary, across 278 of 286 formularies. The most common placement is tier 2 (2,787 plans, 58.9% of those covering it). 1,642 of the covering plans require prior authorization (34.7%), 0 step therapy and 0 a quantity limit.
3,280 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $0, 1,805 of them $0; 1,450 charge coinsurance instead — median 25% of the drug's cost. Once a member's out-of-pocket drug spending reaches $2,400 in 2027, covered drugs cost $0 for the rest of the year.
2026: 5,469 of 5,496 plans covered it (99.5%); 2027: 4,730 of 5,492 (86.1%).
Of 4,367 plans offered in both years, 1 added it to the formulary and 412 dropped it.
Among plans covering it both years, 840 moved it to a higher tier and 242 to a lower one; 250 added prior authorization and 19 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 661 |
| Tier 2 | 2,787 |
| Tier 3 | 1,032 |
| Tier 4 | 250 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 323 of 323 | 100% | 44.9% |
| Medicare Advantage with drugs (MA-PD) | 2,785 of 3,200 | 87% | 28% |
| Special needs plans (SNP) | 1,622 of 1,969 | 82.4% | 44.2% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 846 of 846 | Tier 2 | 0 |
| UnitedHealthcare | 830 of 830 | Tier 3 | 830 |
| Devoted Health | 0 of 728 | No tier listed | 0 |
| Aetna Medicare | 631 of 631 | Tier 2 | 0 |
| Wellcare | 268 of 268 | Tier 1 | 268 |
| HealthSpring | 226 of 226 | Tier 2 | 0 |
| Kaiser Permanente | 112 of 112 | Tier 2 | 0 |
| SCAN Health Plan | 83 of 83 | Tier 2 | 0 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 80 of 80 | Tier 4 | 0 |
| Alignment Health Plan | 77 of 77 | Tier 3 | 0 |
| Anthem Blue Cross and Blue Shield | 74 of 74 | Tier 2 | 74 |
| Wellpoint | 63 of 63 | Tier 2 | 63 |
| Priority Health Medicare | 40 of 40 | Tier 2 | 0 |
| CarePlus Health Plans, Inc. | 37 of 37 | Tier 2 | 0 |
| Zing Health | 36 of 36 | Tier 2 | 36 |
| Capital Blue Cross | 35 of 35 | Tier 2 | 0 |
| Prominence Health Plan | 29 of 29 | Tier 2 | 0 |
| Medica | 27 of 27 | Tier 2 | 0 |
| Anthem HealthKeepers | 26 of 26 | Tier 2 | 26 |
| Blue Cross Blue Shield of Michigan | 26 of 26 | Tier 2 | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 82 of 114 | 71.9% |
| Alaska | 9 of 9 | 100% |
| American Samoa | 1 of 1 | 100% |
| Arizona | 113 of 147 | 76.9% |
| Arkansas | 75 of 85 | 88.2% |
| California | 397 of 397 | 100% |
| Colorado | 81 of 106 | 76.4% |
| Connecticut | 42 of 54 | 77.8% |
| Delaware | 36 of 43 | 83.7% |
| District of Columbia | 12 of 12 | 100% |
| Florida | 438 of 545 | 80.4% |
| Georgia | 133 of 149 | 89.3% |
| Guam | 1 of 1 | 100% |
| Hawaii | 32 of 50 | 64% |
| Idaho | 45 of 45 | 100% |
| Illinois | 108 of 132 | 81.8% |
| Indiana | 115 of 138 | 83.3% |
| Iowa | 59 of 64 | 92.2% |
| Kansas | 73 of 84 | 86.9% |
| Kentucky | 111 of 121 | 91.7% |
| Louisiana | 102 of 125 | 81.6% |
| Maine | 52 of 52 | 100% |
| Maryland | 49 of 49 | 100% |
| Massachusetts | 89 of 89 | 100% |
| Michigan | 158 of 182 | 86.8% |
| Minnesota | 63 of 63 | 100% |
| Mississippi | 94 of 104 | 90.4% |
| Missouri | 139 of 170 | 81.8% |
| Montana | 27 of 27 | 100% |
| Nebraska | 43 of 51 | 84.3% |
| Nevada | 97 of 100 | 97% |
| New Hampshire | 19 of 25 | 76% |
| New Jersey | 67 of 73 | 91.8% |
| New Mexico | 54 of 68 | 79.4% |
| New York | 192 of 215 | 89.3% |
| North Carolina | 140 of 176 | 79.5% |
| North Dakota | 26 of 26 | 100% |
| Northern Mariana Islands | 1 of 1 | 100% |
| Ohio | 149 of 171 | 87.1% |
| Oklahoma | 69 of 81 | 85.2% |
| Oregon | 69 of 92 | 75% |
| Pennsylvania | 284 of 323 | 87.9% |
| Puerto Rico | 64 of 64 | 100% |
| Rhode Island | 29 of 29 | 100% |
| South Carolina | 81 of 89 | 91% |
| South Dakota | 30 of 30 | 100% |
| Tennessee | 118 of 156 | 75.6% |
| Texas | 354 of 407 | 87% |
| U.S. Virgin Islands | 1 of 1 | 100% |
| Utah | 43 of 53 | 81.1% |
| Vermont | 14 of 14 | 100% |
| Virginia | 128 of 144 | 88.9% |
| Washington | 92 of 114 | 80.7% |
| West Virginia | 68 of 69 | 98.6% |
| Wisconsin | 96 of 96 | 100% |
| Wyoming | 13 of 13 | 100% |
Medicare Part D paid for 3,500,762 30-day fills of Meclizine in 2024 for about 1,415,547 enrollees, at an average total cost of $7.13 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Meclizine and the rest of a client's list on every plan in their county.
Estimate Meclizine costs by plan
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.